➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Medtronic
Dow
Harvard Business School
Boehringer Ingelheim

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Betadex


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Betadex?

Betadex is an investigational drug.

There have been 9 clinical trials for Betadex. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2016.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Niemann-Pick Diseases. The leading clinical trial sponsors are Bayer, Ligand Pharmaceuticals, and Medpace, Inc.

There are two US patents protecting this investigational drug and thirty-one international patents.

Recent Clinical Trials for Betadex
TitleSponsorPhase
Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440Janssen Research & Development, LLCPhase 1
Adrabetadex for Patients With Nerve Symptoms of Niemann-Pick Type C Disease (NPC)Vtesse, Inc., a Mallinckrodt Pharmaceuticals CompanyPhase 3
A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (ProbeJanssen Sciences Ireland UCPhase 1

See all Betadex clinical trials

Clinical Trial Summary for Betadex

Top disease conditions for Betadex
Top clinical trial sponsors for Betadex

See all Betadex clinical trials

US Patents for Betadex

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Betadex   Start Trial Therapeutic and imaging compositions and uses thereof Purdue Research Foundation (West Lafayette, IN)   Start Trial
Betadex   Start Trial Pharmaceutical composition for preventing or treating skin cancer comprising Panax spp. plant extract and method of preventing or treating skin cancer in a subject using the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, KR)   Start Trial
Betadex   Start Trial Low, immune enhancing, dose mtor inhibitors and uses thereof Novartis AG (Basel, CH)   Start Trial
Betadex   Start Trial Polyurethane fiber TORAY OPELONTEX CO., LTD. (Osaka, JP)   Start Trial
Betadex   Start Trial Small molecule HSP70 inhibitors The Trustees of the University of Pennsylvania (Philadelphia, PA) The Wistar Institute of Anatomy and Biology (Philadelphia, PA)   Start Trial
Betadex   Start Trial Compositions and methods for the treatment of intraocular neovascularization and/or leakage Retinal Therapies, LLC (Coronado, CA)   Start Trial
Betadex   Start Trial Methods of treating of diabetes and obesity using FGF21 mutants AMGEN INC. (Thousand Oaks, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Betadex

Drugname Country Document Number Estimated Expiration Related US Patent
Betadex Canada 2911906 2033-05-07   Start Trial
Betadex European Patent Office 2994755 2033-05-07   Start Trial
Betadex World Intellectual Property Organization (WIPO) 2014182804 2033-05-07   Start Trial
Betadex South Korea 101741827 2035-07-10   Start Trial
Betadex South Korea 20170006970 2035-07-10   Start Trial
Betadex Australia 2014348657 2033-11-13   Start Trial
Betadex Australia 2017245411 2033-11-13   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Mallinckrodt
Express Scripts
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.